Rifampicin resistance | ||||
Number of cases | Odds ratio | |||
Characteristics | Resistant (%) | Sensitive (%) | OR [95% CI] | p |
Age (years) | ||||
<20 | 1 (0.01) | 34 (9.5) | - | - |
21 - 40 | 68 (68) | 187 (52.23) | 12.36 [1.66, 92.07] | 0.01 |
41 - 60 | 31 (31) | 12 (3.35) | 8.43 [1.11, 64.01] | 0.03 |
≥61 | 0 (0) | 12 (3.35) | - | - |
Gender | ||||
F | 34 (34) | 133 (37.15) | - | - |
M | 66 (66) | 225 (62.85) | - | - |
Residence | ||||
Bangui | 91 (91.92) | 345 (96.64) | - | - |
Provinces | 8 (8.08) | 12 (3.36) | 2.52 [1, 1.36] | 0.04 |
Type of case | ||||
New cases | 27 (27) | 270 (75.42) | - | - |
Treatment failures | 55 (55) | 26 (7.26) | 21.15 [11.47, 38.99] | 0.001 |
Relapse cases | 15 (15) | 49 (13.69) | 3.06 [1.51, 6.16] | 0.002 |
Lost-to-follow-up treatment cases | 3 (3) | 13 (3.63) | - |